Drugmakers Get DOJ Inquiry on Pharmacy Management Contracts

  • U.S. Attorney in New York issues civil investigative demands
  • J&J says request relates to False Claims Act investigation

Merck & Co., Johnson & Johnson, and Endo International Plc said in securities filings this month that they have received demands for information from the U.S. Attorney’s Office for the Southern District of New York related to their contracts with pharmacy benefit managers.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.